Ototoxicity in Children With High-Risk Neuroblastoma: Prevalence, Risk Factors, and Concordance of Grading Scales—A Report From the Children's Oncology Group

Busulphan-melphalan as a myeloablative therapy (MAT) for high-risk neuroblastoma: Results from the HR-NBL1/SIOPEN trial.

(2017) R. L. Ladenstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

(2013) Susan G Kreissman et al.   LANCET ONCOLOGY

Cisplatin and Aminoglycoside Antibiotics: Hearing Loss and Its Prevention

(2012) Jochen Schacht et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Review: Ototoxic Characteristics of Platinum Antitumor Drugs

(2012) Dalian Ding et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale

(2012) Penelope R. Brock et al.   JOURNAL OF CLINICAL ONCOLOGY

Modeling longitudinal binomial responses: implications from two dueling paradigms

(2011) H. Zhang et al.   JOURNAL OF APPLIED STATISTICS

Clinically accurate assessment and grading of ototoxicity

(2011) Kay W. Chang   LARYNGOSCOPE

Critical Need for International Consensus on Ototoxicity Assessment Criteria

(2010) Edward A. Neuwelt et al.   JOURNAL OF CLINICAL ONCOLOGY

Practical Grading System for Evaluating Cisplatin Ototoxicity in Children

(2010) Kay W. Chang et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study

(2010) Ruth Ladenstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recent Advances in Neuroblastoma

(2010) John M. Maris   NEW ENGLAND JOURNAL OF MEDICINE

Auditory Late Effects of Childhood Cancer Therapy: A Report From the Children's Oncology Group

(2010) S. Grewal et al.   PEDIATRICS

Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma

(2009) Howard M. Katzenstein et al.   CANCER

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

(2009) Colin J D Ross et al.   NATURE GENETICS

The epidemiology of neuroblastoma: a review

(2008) Julia E. Heck et al.   PAEDIATRIC AND PERINATAL EPIDEMIOLOGY

Late effects in survivors of tandem peripheral blood stem cell transplant for high-risk neuroblastoma

(2008) Wendy L. Hobbie et al.   PEDIATRIC BLOOD & CANCER

Ototoxicity in children treated for osteosarcoma

(2008) Matthew J. Lewis et al.   PEDIATRIC BLOOD & CANCER